Medicare Advantage plans attract over half of Medicare enrollees but face scrutiny for claim delays and hospital network restrictions, prompting legislative transparency efforts.
CMS proposes major changes to Medicare Advantage Star Ratings, removing administrative measures and focusing on patient outcomes with mixed reactions from healthcare stakeholders.
A federal court ruling invalidates a key HHS rule on Medicare Advantage audits, complicating efforts to curb overpayments and fraud in the program. Congressional reforms are urged to strengthen oversight and payment integrity.
UnitedHealth Group's fair value estimate nudges higher amid improving Medicare Advantage margins, strategic restructuring at Optum, and evolving Affordable Care Act subsidy dynamics. Analysts weigh valuation and market risks.
Medicare Part B premiums will increase 9.7% in 2026, reducing Social Security benefit gains. Learn about the impact on retirees, rising deductibles, and strategies to manage higher Medicare costs.
A federal court ruling invalidates HHS audits of Medicare Advantage plans, complicating efforts to curb upcoding and fraud. Legislative reform is critical to protect taxpayer funds and improve oversight in Medicare Advantage.
The 2026 Medicare Advantage market confronts challenges from regulatory changes, insurer profitability strategies, and shifts in beneficiary enrollment impacting healthcare access and market dynamics.
Analysis of Medicare Advantage plans highlights higher costs, restricted care access, and regulatory barriers compared to Traditional Medicare, impacting seniors and healthcare providers.
CMS proposes new Medicare rule to cover hemp-derived CBD products compliant with federal and state law, expanding treatment options for seniors and impacting healthcare costs.
MedPAC analysis reveals Medicare Advantage plans cost 6% more than traditional Medicare, impacting enrollment and Medicare Part B premiums. Policy reforms needed.
